• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Pharmagenesis selling Feridex in China

Article

Following approval by the Chinese State Drug Administration, Pharmagenesis has begun selling a liver-specific MRI agent in China. The agent, Feridex, was developed by Advanced Magnetics. About 240 million people in China are carriers of the hepatitis B

Following approval by the Chinese State Drug Administration, Pharmagenesis has begun selling a liver-specific MRI agent in China. The agent, Feridex, was developed by Advanced Magnetics. About 240 million people in China are carriers of the hepatitis B virus, a leading cause of hepatoma, which is one of the 10 most frequently occurring cancers in China.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.